HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Turnover of alpha-2-antiplasmin in patients with acute promyelocytic leukemia.

Abstract
Patients with acute promyelocytic leukemia have a bleeding disorder which was thus far explained by a coagulopathy based on diffuse intravascular coagulation (DIC). We observed severe alpha-2-antiplasmin deficiency in a consecutive series of such patients. We postulate proteolysis rather than DIC, also because of increased turnover of 125I-alpha-2-antiplasmin, to be responsible for the coagulopathy. Alpha-2-antiplasmin deficiency may well contribute to the bleeding disorder in acute promyelocytic leukemia.
AuthorsL H Kahle, G Avvisati, R J Lamping, T Moretti, F Mandelli, J W ten Cate
JournalScandinavian journal of clinical and laboratory investigation. Supplementum (Scand J Clin Lab Invest Suppl) Vol. 178 Pg. 75-80 ( 1985) ISSN: 0085-591X [Print] Norway
PMID2418490 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Blood Coagulation Factors
  • alpha-2-Antiplasmin
  • Antithrombin III
  • Plasminogen
Topics
  • Antithrombin III (analysis)
  • Blood Coagulation Factors (analysis)
  • Blood Coagulation Tests
  • Humans
  • Leukemia, Myeloid, Acute (blood, drug therapy)
  • Plasminogen (analysis)
  • Platelet Count
  • Reference Values
  • alpha-2-Antiplasmin (deficiency, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: